ThromboGenics N.V. - Business Update (us. ---------------------------------...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> BIOLOGY >> TECHNOLOGY

ThromboGenics N.V. - Business Update

Date:5/13/2008

us.

---------------------------------

(1) Cell, 2 November 2007, ANTI-PlGF INHIBITS GROWTH OF VEGF(R)-INHIBITOR RESISTANT TUMORS WITHOUT AFFECTING HEALTHY VESSELS - Christian Fischer, Bart Jonckx, Massimiliano Mazzone, Serena Zacchigna, Monica Autiero, Emmanuel Chorianopoulos, Marta Koch, Maria Demol, Sabine Wyns, Lucia Pattarini, Nico van Rooijen, Stephane Plaisance, Mauro Giacca, Mieke Dewerchin, Lieve Moons, Jean Marie Stassen, Desire Collen & Peter Carmeliet

For further information please contact:

ThromboGenics:

Prof. Desire Collen, Tel: +32(0)16-34-61-94;

Dr. Patrik De Haes, Fax +32(0)16-34-61-34.

Citigate Dewe Rogerson:

Sylvie Berrebi / Amber Bielecka / David Dible,

Tel: +44(0)207-638-95-71,

Mobile: +44(0)7767-771-533.

SOURCE ThromboGenics NV
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7
Related biology technology :

1. ThromboGenics - Business Update and Interim Results for the Seven Month Period Ending 30 June 2007
2. ThromboGenics Announces Successful Completion of Technology Transfer to Bharat Biotech for Production of Novel Thrombolytic Agent
3. ThromboGenics and BioInvent Announce Successful Completion of Phase I Clinical Trial of the Anticoagulant TB-402
4. ThromboGenics and BioInvent Announce Publication of Exciting Data on a Novel Class of Angiogenesis Inhibitors in Cell
5. ThromboGenics Presents Results of the Vitreomacular Traction Trial (MIVI IIT) at the American Society of Retina Specialists Annual Meeting
6. ThromboGenics Presents Results of the Phase I Trial of TB-402 at the Prestigious American Society of Hematology Annual Meeting
7. ThromboGenics and BioInvent Receive Approval to Begin Clinical Trials of TB-403 for the Treatment of Cancer
8. ThromboGenics Announces 2007 Full Year Results
9. ThromboGenics Completes Patient Enrolment of MITI IV Trial, a Phase II Study Evaluating the Safety and Preliminary Efficacy of Microplasmin in the Treatment of Acute Stroke
10. Boston Scientific to Explore Sale of Cardiac Surgery and Vascular Surgery Businesses
11. DuPont Leaders Brief Investors on Agriculture Businesses

Post Your Comments:

Breaking Biology Technology:Northwest Biotherapeutics Announces Appointment of Robert A. Farmer to the Board of Directors 2 Northwest Biotherapeutics Announces Appointment of Robert A. Farmer to the Board of Directors 3 Sangart, Inc. Receives European Orphan Drug Designation for the Use of MP4CO in Patients With Sickle Cell Disease 2 Sangart, Inc. Receives European Orphan Drug Designation for the Use of MP4CO in Patients With Sickle Cell Disease 3 Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics 2 Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics 3 Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics 4

[0] Northwest Biotherapeutics Announces Appointment of Robert A. Farmer to the Board of Directors [0] Quest Diagnostics Declares Quarterly Cash Dividend [0] Sangart, Inc. Receives European Orphan Drug Designation for the Use of MP4CO in Patients With Sickle Cell Disease [0] Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics

Other Biology Technology:PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in General Surgery 2 PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in General Surgery 3 PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in General Surgery 4 Sagent Pharmaceuticals Launches Ceftazidime for Injection, USP 2

PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in General Surgery Sagent Pharmaceuticals Launches Ceftazidime for Injection, USP United Therapeutics to Announce Second Quarter 2008 Financial Results Before Market Open on Thursday, July 31, 2008

Breaking Biology News(10 mins):ESHRE announces its campus workshop: 'Artificial Insemination: An Update' 2 UT Southwestern receives $700,000 from HHMI to promote medical education of Ph.D. students 2 The pitch of blue whale songs is declining around the world, scientists discover 2 The pitch of blue whale songs is declining around the world, scientists discover 3 The Chopra Center for Wellbeing Launches Vedamune 3A An Ayurvedic Supplement to Support The Immune System 62586 1 The Chopra Center for Wellbeing Launches Vedamune 3A An Ayurvedic Supplement to Support The Immune System 62586 2 American Red Cross Wins Court Injunction Against Striking Teamsters 62584 1 American Red Cross Wins Court Injunction Against Striking Teamsters 62584 2 Senate Approval of Mikulski Amendment Further Opens Health Care Bill to Massive Federal Funding of Abortion 62581 1 Senate Approval of Mikulski Amendment Further Opens Health Care Bill to Massive Federal Funding of Abortion 62581 2

[0] ESHRE announces its campus workshop: 'Artificial Insemination: An Update'[0] UT Southwestern receives $700,000 from HHMI to promote medical education of Ph.D. students [0] The pitch of blue whale songs is declining around the world, scientists discover

Other Biology News:K-Staters design and build a low-cost remote sensing tool for environmental studies 2 K-Staters design and build a low-cost remote sensing tool for environmental studies 3 Gene linked to rare disease activates fat breakdown 2 Selectively blocking inflammatory signals may protect mice from MS 2

K-Staters design and build a low-cost remote sensing tool for environmental studies Gene linked to rare disease activates fat breakdown Selectively blocking inflammatory signals may protect mice from MS

Biology Products:

BD BioCoat Vented Caps for 175 cm2 Flasks from BD Biosciences - Discovery Labware BD BioCoat Poly-D-Lysine 60 mm Culture Dishes from BD Biosciences - Discovery Labware BD Falcon Center-well Organ Culture Dish, In Vitro Fertilization Dish from BD Biosciences - Discovery Labware Mouse Anti-Human MHC II (HLA-DP) Monoclonal Antibody, Unconjugated, Clone SPM421 from Spring Bioscience